Latest profit margin for BioNeutra Global: -5.62% — see history and peer comparisons.
Get informed when a big investor buys or sells
+ FollowAs of Sep 2024
Trailing 12 months ending Sep 2024
The latest profit margin for BGACF is -5.62% as of September 2024. That compares with -41.81% in the prior-year period — up 86.6% year over year. That is below the sector sector average of 13.4%. Investors often review this figure alongside BioNeutra Global's historical trend and sector peers before judging valuation or financial health.
Over the past year, BGACF's profit margin moved from -41.81% to -5.62% — a 86.6% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in BioNeutra Global's valuation or profitability profile.
Against its sector companies, BGACF currently prints -5.62% for profit margin, while the sector average sits near 13.4%. That is roughly 141.9% below the sector mean. Large gaps often invite a closer look at BioNeutra Global's growth, margins, and balance sheet.
Profit Margin shows how effectively BioNeutra Global converts resources into returns. At -5.62%, BGACF may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -41.81% in the prior-year period — up 86.6% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.
After noting BGACF's profit margin (-5.62%), review year-over-year change from -41.81%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.